Balance Labs Stock Probability of Future Pink Sheet Price Finishing Over 0.20
| BLNC Stock | USD 0.21 0.00 0.00% |
Balance |
Balance Labs Target Price Odds to finish over 0.20
The tendency of Balance Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 0.20 in 90 days |
| 0.21 | 90 days | 0.20 | about 19.64 |
Based on a normal probability distribution, the odds of Balance Labs to stay above $ 0.20 in 90 days from now is about 19.64 (This Balance Labs probability density function shows the probability of Balance Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Balance Labs price to stay between $ 0.20 and its current price of $0.21 at the end of the 90-day period is about 15.27 .
Given the investment horizon of 90 days Balance Labs has a beta of -1.02 suggesting Additionally Balance Labs has an alpha of 0.2591, implying that it can generate a 0.26 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Balance Labs Price Density |
| Price |
Predictive Modules for Balance Labs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Balance Labs. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Balance Labs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Balance Labs is not an exception. The market had few large corrections towards the Balance Labs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Balance Labs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Balance Labs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.26 | |
β | Beta against Dow Jones | -1.02 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.11 |
Balance Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Balance Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Balance Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Balance Labs has some characteristics of a very speculative penny stock | |
| Balance Labs currently holds 468.81 K in liabilities. Balance Labs has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Balance Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Balance Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Balance Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Balance to invest in growth at high rates of return. When we think about Balance Labs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 624.59 K. Net Loss for the year was (796.7 K) with profit before overhead, payroll, taxes, and interest of 479.12 K. | |
| Balance Labs currently holds about 227.77 K in cash with (56) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 87.0% of the company shares are held by company insiders |
Balance Labs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Balance Pink Sheet often depends not only on the future outlook of the current and potential Balance Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Balance Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.7 M | |
| Cash And Short Term Investments | 227.6 K |
Balance Labs Technical Analysis
Balance Labs' future price can be derived by breaking down and analyzing its technical indicators over time. Balance Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Balance Labs. In general, you should focus on analyzing Balance Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Balance Labs Predictive Forecast Models
Balance Labs' time-series forecasting models is one of many Balance Labs' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Balance Labs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Balance Labs
Checking the ongoing alerts about Balance Labs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Balance Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Balance Labs has some characteristics of a very speculative penny stock | |
| Balance Labs currently holds 468.81 K in liabilities. Balance Labs has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Balance Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Balance Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Balance Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Balance to invest in growth at high rates of return. When we think about Balance Labs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 624.59 K. Net Loss for the year was (796.7 K) with profit before overhead, payroll, taxes, and interest of 479.12 K. | |
| Balance Labs currently holds about 227.77 K in cash with (56) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 87.0% of the company shares are held by company insiders |
Other Information on Investing in Balance Pink Sheet
Balance Labs financial ratios help investors to determine whether Balance Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balance with respect to the benefits of owning Balance Labs security.